vMIP-II

N/A

Report date: 2025/03/20 20:00:06

NME

Base Information

Drug NamevMIP-II

Drug Alias Namechemokine antagonists (GW)

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionC-C chemokine receptor type 3 antagonistsC-C chemokine receptor type 5 antagonistsC-X-C motif chemokine receptor 4 antagonists +[4]

TargetsC-C chemokine receptor type 5C-C chemokine receptor type 3G-protein coupled receptor homolog US28 +[4]

Therapy Area/IndicationsHIV Infections

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited Kingdom

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesGlaxo Group Ltd

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesGlaxo Group Ltd

Active IndicationsN/A

Inactive IndicationsHIV Infections

Other Information

ATC CodeN/A